Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 475152, 10 pages
http://dx.doi.org/10.1155/2014/475152
Research Article

Peripheral Injection of SB203580 Inhibits the Inflammatory-Dependent Synthesis of Proinflammatory Cytokines in the Hypothalamus

1Polish Academy of Sciences, The Kielanowski Institute of Animal Physiology and Nutrition, 05-110 Jabłonna, Poland
2The Academy of Cosmetics and Health Care, 13 Podwale Street, 00-252 Warsaw, Poland

Received 24 February 2014; Revised 9 May 2014; Accepted 20 May 2014; Published 4 June 2014

Academic Editor: Kanato Yamagata

Copyright © 2014 Andrzej P. Herman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Kluger, “Fever: role of pyrogens and cryogens,” Physiological Reviews, vol. 71, no. 1, pp. 93–127, 1991. View at Google Scholar · View at Scopus
  2. C. B. Lawrence and N. J. Rothwell, “Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat,” Journal of Neuroendocrinology, vol. 13, no. 6, pp. 490–495, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. A. P. Herman and D. Tomaszewska-Zaremba, “Effect of endotoxin on the expression of GnRH and GnRHR genes in the hypothalamus and anterior pituitary gland of anestrous ewes,” Animal Reproduction Science, vol. 120, no. 1–4, pp. 105–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Ebisui, J. Fukata, T. Tominaga et al., “Roles of interleukin-1α and -1β in endotoxin-induced suppression of plasma gonadotropin levels in rats,” Endocrinology, vol. 130, no. 6, pp. 3307–3313, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Palomba and M. Bentivoglio, “Chronic inflammation affects the photic response of the suprachiasmatic nucleus,” Journal of Neuroimmunology, vol. 193, no. 1-2, pp. 24–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Erickson and W. A. Banks, “Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis,” Brain, Behavior, and Immunity, vol. 25, no. 8, pp. 1637–1648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. A. Creasey, P. Stevens, J. Kenney et al., “Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli,” Circulatory Shock, vol. 33, no. 2, pp. 84–91, 1991. View at Google Scholar · View at Scopus
  8. A. P. Herman, T. Misztal, A. Herman, and D. Tomaszewska-Zaremba, “Expression of Interleukin (IL)-1β and IL-1 receptors genes in the hypothalamus of anoestrous ewes after lipopolysaccharide treatment,” Reproduction in Domestic Animals, vol. 45, no. 6, pp. e426–e433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. G. de Simoni, L. Terreni, R. Chiesa, F. Mangiarotti, and G. L. Forloni, “Inteferon-γ potentiates interleukin (IL)-6 and tumor necrosis factor- α but not IL-1β induced by endotoxin in the brain,” Endocrinology, vol. 138, no. 12, pp. 5220–5226, 1997. View at Google Scholar · View at Scopus
  10. W. A. Banks, “Cytokines and the blood-brain barrier,” in The Neuroimmunological Basis of Behavior and Mental Disorders, pp. 3–17, Springer, 2009. View at Google Scholar
  11. R. Dantzer, “Cytokine, sickness behavior, and depression,” Neurologic Clinics, vol. 24, no. 3, pp. 441–460, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. A. Banks, A. J. Kastin, and R. D. Broadwell, “Passage of cytokines across the blood-brain barrier,” NeuroImmunoModulation, vol. 2, no. 4, pp. 241–248, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Kakizaki, H. Watanobe, A. Kohsaka, and T. Suda, “Temporal profiles of interleukin-1β, interleukin-6, and tumor necrosis factor-α in the plasma and hypothalamic paraventricular nucleus after intravenous or intraperitoneal administration of lipopolysaccharide in the rat: estimation by push-pull perfusion,” Endocrine Journal, vol. 46, no. 4, pp. 487–496, 1999. View at Google Scholar · View at Scopus
  14. M. K. Hansen, K. T. Nguyen, L. E. Goehler et al., “Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1β protein in rats,” Autonomic Neuroscience: Basic and Clinical, vol. 85, no. 1–3, pp. 119–126, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Laye, R.-M. Bluthe, S. Kent et al., “Subdiaphragmatic vagotomy blocks induction of IL-1β mRNA in mice brain in response to peripheral LPS,” American Journal of Physiology. Regulatory Integrative and Comparative Physiology, vol. 268, no. 5, pp. R1327–R1331, 1995. View at Google Scholar · View at Scopus
  16. G. P. Chrousos, “The stress response and immune function: clinical implications. The 1999 Novera H. Spector lecture,” Annals of the New York Academy of Sciences, vol. 917, pp. 38–67, 2000. View at Google Scholar · View at Scopus
  17. P. Taishi, L. Churchill, A. De, F. Obal Jr., and J. M. Krueger, “Cytokine mRNA induction by interleukin-1β or tumor necrosis factor α in vitro and in vivo,” Brain Research, vol. 1226, pp. 89–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. E. Mrak and W. S. T. Griffin, “Interleukin-1 and the immunogenetics of Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 59, no. 6, pp. 471–476, 2000. View at Google Scholar · View at Scopus
  19. L. Vitkovic, J. Bockaert, and C. Jacque, “‘Inflammatory’ cytokines' neuromodulators in normal brain?” Journal of Neurochemistry, vol. 74, no. 2, pp. 457–471, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. S. V. Vellucci, R. F. Parrott, A. C. Da Costa, S. Ohkura, and K. M. Kendrick, “Increased body temperature, cortisol secretion, and hypothalamic expression of c-fos, corticotrophin releasing hormone and interleukin-1β mRNAs, following central administration of interleukin-1β in the sheep,” Molecular Brain Research, vol. 29, no. 1, pp. 64–70, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. A. P. Herman, T. Misztal, K. Romanowicz, and D. Tomaszewska-Zaremba, “Central injection of exogenous IL-1β in the control activities of hypothalamic-pituitary-gonadal axis in anestrous ewes,” Reproduction in Domestic Animals, vol. 47, no. 1, pp. 44–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Rivest and C. Rivier, “Centrally injected interleukin-1 beta inhibits the hypothalamic LHRH secretion and circulating LH levels via prostaglandins in rats,” Journal of Neuroendocrinology, vol. 5, no. 4, pp. 445–450, 1993. View at Google Scholar · View at Scopus
  23. S. Kumar, M. S. Jiang, J. L. Adams, and J. C. Lee, “Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase,” Biochemical and Biophysical Research Communications, vol. 263, no. 3, pp. 825–831, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. S. P. Davies, H. Reddy, M. Caivano, and P. Cohen, “Specificity and mechanism of action of some commonly used protein kinase inhibitors,” Biochemical Journal, vol. 351, no. 1, pp. 95–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Baldassare, Y. Bi, and C. J. Bellone, “The role of p38 mitogen-activated protein kinase in IL-1β transcription,” Journal of Immunology, vol. 162, no. 9, pp. 5367–5373, 1999. View at Google Scholar · View at Scopus
  26. J. C. Lee, J. T. Laydon, P. C. McDonnell et al., “A protein kinase involved in the regulation of inflammatory cytokine biosynthesis,” Nature, vol. 372, no. 6508, pp. 739–746, 1994. View at Google Scholar · View at Scopus
  27. C. Thirunavukkarasu, S. C. Watkins, and C. R. Gandhi, “Mechanisms of endotoxin-induced NO, IL-6, and TNF-α production in activated rat hepatic stellate cells: role of p38 MAPK,” Hepatology, vol. 44, no. 2, pp. 389–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Welento, S. Szteyn, and Z. Milart, “Observations on the stereotaxic configuration of the hypothalamus nuclei in the sheep,” Anatomischer Anzeiger, vol. 124, no. 1, pp. 1–27, 1969. View at Google Scholar · View at Scopus
  29. R. Rasmussen, “Quantification on the LightCycler,” in Rapid Cycle Real-Time PCR Methods and Applications, S. Meuer, C. Wittwer, and K. Nakagawara, Eds., Berlin, Germany, 2001. View at Google Scholar
  30. M. W. Pfaffl, A. Tichopad, C. Prgomet, and T. P. Neuvians, “Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: bestKeeper–excel-based tool using pair-wise correlations,” Biotechnology Letters, vol. 26, no. 6, pp. 509–515, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Layé, G. Gheusi, S. Cremona et al., “Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression,” American Journal of Physiology. Regulatory Integrative and Comparative Physiology, vol. 279, no. 1, pp. R93–R98, 2000. View at Google Scholar · View at Scopus
  32. A. J. Dunn, “Effects of cytokines and infections on brain neurochemistry,” Clinical Neuroscience Research, vol. 6, no. 1-2, pp. 52–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. N. J. Busbridge, M. J. Dascombe, F. J. H. Tilders, J. W. A. M. Van Oers, E. A. Linton, and N. J. Rothwell, “Central activation of thermogenesis and fever by interleukin-1β and interleukin-1α involves different mechanisms,” Biochemical and Biophysical Research Communications, vol. 162, no. 2, pp. 591–596, 1989. View at Google Scholar · View at Scopus
  34. A. J. Dunn, “Cytokine activation of the HPA axis,” Annals of the New York Academy of Sciences, vol. 917, pp. 608–617, 2000. View at Google Scholar · View at Scopus
  35. T. M. O'Connor, D. J. O'Halloran, and F. Shanahan, “The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia,” QJM, vol. 93, no. 6, pp. 323–333, 2000. View at Google Scholar · View at Scopus
  36. L. Yang, K. Lindholm, Y. Konishi, R. Li, and Y. Shen, “Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways,” Journal of Neuroscience, vol. 22, no. 8, pp. 3025–3032, 2002. View at Google Scholar · View at Scopus
  37. R. A. French, R. W. Vanhoy, R. Chizzonite et al., “Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice,” Journal of Neuroimmunology, vol. 93, no. 1-2, pp. 194–202, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. P. März, K. Heese, B. Dimitriades-Schmutz, S. Rose-John, and U. Otten, “Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression,” Glia, vol. 26, no. 3, pp. 191–200, 1999. View at Google Scholar
  39. E. M.-H. Ban, “Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography,” ImmunoMethods, vol. 5, no. 1, pp. 31–40, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. A. P. Herman, A. Krawczyńska, J. Bochenek et al., “Inhibition of acetylcholinesterase activity by rivastigmine decreases lipopolysaccharide-induced IL-1β expression in the hypothalamus of ewes,” Domestic Animal Endocrinology, vol. 44, no. 3, pp. 109–114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. M.-M. Gabellec, R. Griffais, G. Fillion, and F. Haour, “Interleukin-1 receptors type I and type II in the mouse brain: kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide,” Journal of Neuroimmunology, vol. 66, no. 1-2, pp. 65–70, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Takao, K. Hashimoto, and E. B. de Souza, “Interleukin-1 receptors in the brain-endocrine-immune axis—modulation by stress and infection,” Annals of the New York Academy of Sciences, vol. 771, pp. 372–385, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Patil, X. Zhu, C. Rossa Jr., Y. J. Kim, and K. L. Kirkwood, “p38 MAPK regulates IL-1β induced IL-6 expression through mRNA stability in osteoblasts,” Immunological Investigations, vol. 33, no. 2, pp. 213–233, 2004. View at Google Scholar · View at Scopus
  44. A. Cuenda and S. Rousseau, “p38 MAP-Kinases pathway regulation, function and role in human diseases,” Biochimica et Biophysica Acta. Molecular Cell Research, vol. 1773, no. 8, pp. 1358–1375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Shapiro and C. A. Dinarello, “Osmotic regulation of cytokine synthesis in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 26, pp. 12230–12234, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Beyaert, A. Cuenda, W. V. Berghe et al., “The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor,” EMBO Journal, vol. 15, no. 8, pp. 1914–1923, 1996. View at Google Scholar · View at Scopus
  47. A. Simi, M. Porsmyr-Palmertz, A. Hjertén, M. Ingelman-Sundberg, and N. Tindberg, “The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1β signalling but not its biosynthesis in rat cortical glial cells,” Journal of Neurochemistry, vol. 83, no. 3, pp. 727–737, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. A. M. Badger, J. N. Bradbeer, B. Votta, J. C. Lee, J. L. Adams, and D. E. Griswold, “Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function,” Journal of Pharmacology and Experimental Therapeutics, vol. 279, no. 3, pp. 1453–1461, 1996. View at Google Scholar · View at Scopus
  49. W.-D. Zhou, H.-M. Yang, Q. Wang et al., “SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model,” Human Reproduction, vol. 25, no. 12, pp. 3110–3116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. C. A. Dinarello, “Anti-inflammatory agents: present and future,” Cell, vol. 140, no. 6, pp. 935–950, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Fong, K. J. Tracey, L. L. Moldawer et al., “Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia,” Journal of Experimental Medicine, vol. 170, no. 5, pp. 1627–1633, 1989. View at Google Scholar · View at Scopus
  52. R. Goldbach-Mansky, N. J. Dailey, S. W. Canna et al., “Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition,” New England Journal of Medicine, vol. 355, no. 6, pp. 581–592, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Pollak, A. Gilboa, O. Ben-Menachem, T. Ben-Hur, H. Soreq, and R. Yirmiya, “Acetylcholinesterase inhibitors reduce brain and blood interleukin-1β production,” Annals of Neurology, vol. 57, no. 5, pp. 741–745, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. L. V. Borovikova, S. Ivanova, M. Zhang et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, no. 6785, pp. 458–462, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. J.-M. Waldburger, D. L. Boyle, M. Edgar et al., “Spinal p38 MAP kinase regulates peripheral cholinergic outflow,” Arthritis and Rheumatism, vol. 58, no. 9, pp. 2919–2921, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Katholnig, C. C. Kaltenecker, H. Hayakawa et al., “P38α senses environmental stress to control innate immune responses via mechanistic target of rapamycin,” Journal of Immunology, vol. 190, no. 4, pp. 1519–1527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Kim, Y. Sano, K. Todorova et al., “The kinase p38α serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression,” Nature Immunology, vol. 9, no. 9, pp. 1019–1027, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. Z. Yang, X. Zhang, P. A. Darrah, and D. M. Mosser, “The regulation of Th1 responses by the p38 MAPK,” Journal of Immunology, vol. 185, no. 10, pp. 6205–6213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. X. Guo, R. E. Gerl, and J. W. Schrader, “Defining the involvement of p38α MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase,” Journal of Biological Chemistry, vol. 278, no. 25, pp. 22237–22242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. T. H. Page, A. Brown, E. M. Timms, B. M. J. Foxwell, and K. P. Ray, “Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo,” Arthritis and Rheumatism, vol. 62, no. 11, pp. 3221–3231, 2010. View at Publisher · View at Google Scholar · View at Scopus